| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | T0901317 | GDSC1000 | pan-cancer | AAC | 0.029 | 0.4 |
| mRNA | VX-702 | GDSC1000 | pan-cancer | AAC | 0.031 | 0.4 |
| mRNA | nintedanib | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.057 | 0.4 |
| mRNA | SGC0946 | GDSC1000 | pan-cancer | AAC | -0.03 | 0.4 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | SR8278 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.4 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.4 |
| mRNA | BRD-K03536150 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | BRD-K51831558 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.4 |